YPrime in Action: A Pediatric Angelman Syndrome Study
A leading biotech company faced significant challenges while conducting a study on pediatric Angelman syndrome, a genetic disorder marked by developmental disabilities. Their existing eCOA solution failed to meet the stringent requirements for data oversight, quality, and regulatory compliance. The company required a vendor switch during the open-label extension (OLE) phase to enhance its data management and ensure a smooth transition.
The Challenge
The Solution
YPrime introduced a tailored eCOA solution designed to meet the sponsor’s unique needs:
Register to Download the Full Case Study
Discover how YPrime’s advanced eCOA platform transformed a challenging study into a success story. Register now to access the rare disease case study and learn how we can deliver the same high-quality solutions for your clinical research.
By registering, you’ll gain exclusive insights into our innovative solutions and receive updates on how YPrime continues to lead the way in clinical research technology.